Mean platelet volume in patients with type 2 diabetes mellitus

被引:300
作者
Papanas, N
Symeonidis, G
Maltezos, E
Mavridis, G
Karavageli, E
Vosnakidis, T
Lakasas, G
机构
[1] Democritus Univ Thrace, Dept Internal Med 2, Komotini, Greece
[2] Gen Hosp Thessaloniki O Agios Dimitrios, Dept Diabet, Thessaloniki, Greece
[3] Gen Hosp Thessaloniki O Agios Dimitrios, Haematol Lab, Thessaloniki, Greece
关键词
D O I
10.1080/0953710042000267707
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aim of the study: To evaluate mean platelet volume (MPV) in type 2 diabetic versus non-diabetic patients, as well as to investigate the associations between MPV and diabetic complications. Materials and methods: This study included 416 patients divided into two groups. Group A comprised 265 type 2 diabetic patients ( 131 men) with a mean age of 67.4 +/- 9.5 years and a mean diabetes duration of 14.5 +/- 5.7 years. Group B comprised 151 non-diabetic patients ( 74 men) with a mean age of 68.6 +/- 9.1 years. MPV ( blood samples anticoagulated with sodium citrate) was measured in two blood cell counters (Sysmex SF 3000 and Cell-Dyn 3700). Results: MPV was significantly higher (P=0.01) in group A ( 14.2 +/- 2.2 fl) than in group B ( 7.1 +/- 1.2 fl). In group A MPV was significantly higher ( P=0.043) in patients with retinopathy (15.8 +/- 1.3 fl) than in patients without retinopathy ( 10.9 +/- 1.1 fl) and also significantly higher ( P=0.044) in patients with microalbuminuria (15.6 +/- 1.2 fl) than in patients without microalbuminuria ( 10.1 +/- 1.2 fl). No association, however, was found in group A between MPV and age, gender, duration of diabetes, insulin dependency, BMI, HbA(1c), coronary artery disease or dyslipidaemia. Conclusions: MPV is higher in type 2 diabetic patients than in non-diabetic patients. Among type 2 diabetic patients MPV is higher in those who have microvascular complications ( retinopathy or microalbuminuria).
引用
收藏
页码:475 / 478
页数:4
相关论文
共 32 条
[1]  
American Diabetes Association, 2003, DIABETES CARE S1, V26, pS94
[2]   Platelet size: Measurement, physiology and vascular disease [J].
Bath, PMW ;
Butterworth, RJ .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) :157-161
[3]   INCREASED PLATELET VOLUME AND PLATELET MASS IN PATIENTS WITH ATHEROSCLEROTIC RENAL-ARTERY STENOSIS [J].
BATH, PMW ;
MISSOURIS, CG ;
BUCKENHAM, T ;
MACGREGOR, GA .
CLINICAL SCIENCE, 1994, 87 (02) :253-257
[4]   PLATELET-FUNCTION IN DIABETES-MELLITUS IN RELATIONSHIP TO COMPLICATIONS, GLYCOSYLATED HEMOGLOBIN AND SERUM-LIPOPROTEINS [J].
BETTERIDGE, DJ ;
ZAHAVI, J ;
JONES, NAG ;
SHINE, B ;
KAKKAR, VV ;
GALTON, DJ .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1981, 11 (04) :273-277
[5]   THE ELECTROCARDIOGRAM IN POPULATION STUDIES - A CLASSIFICATION SYSTEM [J].
BLACKBURN, H ;
KEYS, A ;
SIMONSON, E ;
RAUTAHARJU, P ;
PUNSAR, S .
CIRCULATION, 1960, 21 (06) :1160-1175
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]   Diabetic retinopathy [J].
Fong, DS ;
Cavallerano, JD ;
Aiello, L ;
Ferris, FL ;
Gardner, TW ;
Klein, R ;
King, GL ;
Blankenship, G .
DIABETES CARE, 2003, 26 (01) :226-229
[8]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[9]   PLATELET SURVIVAL IN PATIENTS WITH DIABETES-MELLITUS [J].
JONES, RL ;
PARADISE, C ;
PETERSON, CM .
DIABETES, 1981, 30 (06) :486-489
[10]   PLATELET AGGREGABILITY DURING THE 1ST 2 YEARS OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS IN CHILDREN [J].
KOBBAH, AM ;
EWALD, U ;
TUVEMO, T .
DIABETOLOGIA, 1989, 32 (10) :729-735